EPISODE · Oct 24, 2025 · 15 MIN
E235: Kalshi fields $10B+ valuation offers post-$5B raise; Crusoe $1.38B raise at $10B+ valuation fuels AI infra expansion; Redwood Materials $350M Series E at $6B valuation boosts battery recycling; OpenEvidence $200M Series C at $6B valuation drives med
from This Week in Pre-IPO Stocks · host AG Dillon & Co
Send us Fan Mail00:00 - Intro00:07 - Kalshi Fields $10B+ Valuation Offers Post-$5B Raise01:12 - Crusoe $1.38B Raise at $10B+ Valuation Fuels AI Infra Expansion02:31 - Redwood Materials $350M Series E at $6B Valuation Boosts Battery Recycling04:04 - OpenEvidence $200M Series C at $6B Valuation Drives Medical AI Adoption05:35 - Cohere $7B Tender Offer Amid $150M ARR Enterprise LLM Growth06:40 - Synthesia $4B GV-Led Round Talks Post-Adobe $3B Acquisition Bid08:05 - Suno $100M+ Raise at $2B+ Valuation in AI Music Surge09:04 - Anduril Acquires AIRS to Bolster Multi-Domain Infrared Sensing10:13 - Revolut Mexico Banking Launch Amid $4B Revenue Expansion11:18 - X Launches Inactive Handle Marketplace for Premium Monetization12:10 - Anthropic Tens of Billions Google TPU Deal Expands Compute Footprint13:08 - OpenAI $15B Wisconsin Data Center Partnership with Oracle14:17 - OpenAI Acquires Sky AI Mac Interface Team in Consumer Push
Embed this episode
What this episode covers
Send us Fan Mail 00:00 - Intro 00:07 - Kalshi Fields $10B+ Valuation Offers Post-$5B Raise 01:12 - Crusoe $1.38B Raise at $10B+ Valuation Fuels AI Infra Expansion 02:31 - Redwood Materials $350M Series E at $6B Valuation Boosts Battery Recycling 04:04 - OpenEvidence $200M Series C at $6B Valuation Drives Medical AI Adoption 05:35 - Cohere $7B Tender Offer Amid $150M ARR Enterprise LLM Growth 06:40 - Synthesia $4B GV-Led Round Talks Post-Adobe $3B Acquisition Bid 08:05 - Suno $100M+ Raise at $...
Ready to play
E235: Kalshi fields $10B+ valuation offers post-$5B raise; Crusoe $1.38B raise at $10B+ valuation fuels AI infra expansion; Redwood Materials $350M Series E at $6B valuation boosts battery recycling; OpenEvidence $200M Series C at $6B valuation drives med
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.